Our studies have elaborated the mechanism of AUS_001 as an inhibitor of tubulin polymerization. The favorable safety profile of AUS_001, along with its ability to circumvent Pgp-mediated multidrug resistance, provides potential for efficacy against multiple cancers where microtubule destabilization is proven to be an effective target.
This cell line shows good activity for both transporters (BCRP substrate dantrolene efflux ratio (ER) 16.3 {plus minus} 0.9, Pgp substrate quinidine ER 27.5 {plus minus} 1.2) and use of selective transport inhibitors enables an assessment of the relative contributions to overall ERs...Significance Statement A single cell line, that includes both the major human efflux transporters of the BBB, (MDCKII-MDR1-BCRP) has been established facilitating the rapid identification of efflux substrates and enabling the design of brain penetrant molecules. Efflux ratios using this cell line demonstrate a clear relationship with brain penetration as defined by rat brain K.
5 months ago
Preclinical • Journal
|
ER (Estrogen receptor) • ABCB1 (ATP Binding Cassette Subfamily B Member 1)
This study showed that adjuvant mifamurtide, combined with HDIFO for a poor response to induction chemotherapy, could improve EFS in Pgp+ patients. Overall, the outcomes compared favorably with previous series. Mifamurtide and HDIFO as salvage chemotherapy are worth further study.
2 years ago
P2 data • Retrospective data • Clinical Trial,Phase II • Journal
The activity of PGP-I was further identified to be highly related to the phosphorylation of STAT3, which could be impeded by the natural product parthenolide. Collectively, these findings suggest that PGP-I, which can promote hepatocellular tumor progression through the classical inflammation-/tumor-related IL-6/STAT3 pathway, may serve as a potential HCC biomarker and therapeutic target.
over 2 years ago
Journal
|
IL6 (Interleukin 6) • STAT3 (Signal Transducer And Activator Of Transcription 3)